![U.S. economy adds 143,000 jobs in January, less than anticipated](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEK96067_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.520 | 2.520 | 0.000 |
Stocks | 97.480 | 97.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.380 | 19.823 |
Price to Book | 3.659 | 4.056 |
Price to Sales | 2.173 | 2.426 |
Price to Cash Flow | 15.802 | 16.225 |
Dividend Yield | 2.070 | 1.378 |
5 Years Earnings Growth | 9.727 | 12.179 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.660 | 94.879 |
Consumer Cyclical | 1.340 | 10.020 |
Number of long holdings: 54
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.25 | 870.37 | +3.35% | |
UnitedHealth | US91324P1021 | 4.69 | 530.04 | -1.81% | |
AbbVie | US00287Y1091 | 4.67 | 192.97 | +0.64% | |
Novo Nordisk B | DK0062498333 | 3.95 | 642.5 | +1.18% | |
Merck&Co | US58933Y1055 | 3.85 | 88.05 | -1.81% | |
Thermo Fisher Scientific | US8835561023 | 3.22 | 572.71 | -1.66% | |
Pfizer | US7170811035 | 3.12 | 25.83 | -2.31% | |
Novartis | CH0012005267 | 3.03 | 97.72 | +0.01% | |
Bristol-Myers Squibb | US1101221083 | 2.97 | 57.42 | -3.84% | |
AstraZeneca | GB0009895292 | 2.84 | 11,678.0 | -0.92% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -6.06 | - | ||
FIM Emerging markets ESG | 382.98M | 4.61 | 0.29 | 4.05 | ||
S SaastOrahasto Kohtuullinen | 326.96M | 13.28 | 3.36 | 5.84 | ||
FIM USA | 312.29M | 31.21 | 10.97 | 12.22 | ||
S-Saastorahasto Rohkea | 307.55M | 17.45 | 5.20 | 8.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review